跳至主要内容
临床试验/TCTR20220722004
TCTR20220722004Unknown不适用

Expansion of Integrated AI Solution for Diabetic Retinopathy Screening in Thailand: An implementation research

Health Systems Research Institute (HSRI)0 个研究点目标入组 34,500 人开始时间: 2022年7月22日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
34,500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • 1. Type 1 or 2 diabetes mellitus patients whose name are in primary hospital record 2. No full-time ophthalmologists in those primary hospital 3. Age more than or equal to 18 years 4. Eligible for fundus photo imaging at least 1 eye

排除标准

  • 1. Type 1 or 2 diabetes mellitus patients whose name are in primary hospital record that have full-time ophthalmologists 2. Patients who previously diagnosed with other causes of macular edema, for example, Age-related Macular Degeneration, Radiation Retinopathy, Retinal Vein Occlusion etc. 3. History of retinal laser or surgery 4. Other ocular diseases that require referral to ophthalmologists
  • 5. Not eligible for fundus photo imaging for both eyes (any causes)

研究者

发起方
Health Systems Research Institute (HSRI)

相似试验

Expansion of Integrated AI Solution for Diabetic... | 临床试验